4.63 USD
↗ 0.02 (0.33%)LIVE (AS OF 01:42 PM EDT)
Cytek Biosciences, Inc. Common Stock (CTKB) is currently trading at $4.63. The technical outlook is "Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest CTKB is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Sep 11, 2026.